MedPath
NMPA Approval

Bendamustine Hydrochloride for Injection

国药准字H20244529

July 30, 2024

Drug Information

注射用盐酸苯达莫司汀

注射剂

100mg(以C₁₆H₂₁Cl₂N₃O₂•HCl计)

化学药品

July 30, 2024

Company Information

Applicant Company

上海市浦东新区惠南镇沪南公路9125号

Manufacturing Company

江苏大丰盐土大地海洋生物产业科技园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸苯达莫司汀 - NMPA 批准文号 | MedPath